Correction to: Nature https://doi.org/10.1038/s41586-024-07121-9 Published online 28 February 2024
This article was originally published under standard Springer Nature License (© The Author(s), under exclusive licence to Springer Nature Limited). It is now available as an open-access paper under a Creative Commons Attribution 4.0 International license, © The Author(s). The error has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Guan, X., Hu, R., Choi, Y. et al. Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells. Nature 630, E9 (2024). https://doi.org/10.1038/s41586-024-07562-2
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41586-024-07562-2
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
